Evaluation of polymeric nanoparticle formulations by effective imaging and quantitation of cellular uptake for controlled delivery of doxorubicin

Small

Volumn 11, Issue 9-10, 2015, Pages 1197-1204

  Win, Khin Yin ^a   Teng, Choon Peng ^a,b   Ye, Enyi ^a   Low, Michelle ^a   Han, Ming Yong ^a,b  

^a INSTITUTE OF MATERIALS RESEARCH AND ENGINEERING   (Singapore)

^b NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

Author keywords

[No Author keywords available]

Indexed keywords

CONTROLLED DRUG DELIVERY; ETHYLENE; MOBILE SECURITY; NANOCRYSTALS; NANOPARTICLES; SEMICONDUCTOR QUANTUM DOTS;

CELLULAR INTERACTION; CONTROLLED DELIVERY; CONTROLLED DRUG RELEASE; EFFICIENT DETECTION; EVALUATION PLATFORMS; LUMINESCENT QUANTUM DOTS; NANOPARTICLE FORMULATION; POLYMERIC NANOPARTICLES;

POLYMERS;

CHITOSAN; DOXORUBICIN; DRUG CARRIER; LACTIC ACID; MICROSPHERE; NANOPARTICLE; POLYGLYCOLIC ACID; POLYLACTIC ACID-POLYGLYCOLIC ACID COPOLYMER; POLYMER; QUANTUM DOT; WATER;

3T3 CELL LINE; ANIMAL; CELL LINE; CHEMICAL PHENOMENA; CHEMISTRY; CONFOCAL MICROSCOPY; DRUG DELIVERY SYSTEM; HUMAN; MAGNETISM; MOUSE; NANOTECHNOLOGY; PROCEDURES; RAT; SCANNING ELECTRON MICROSCOPY; SOLUBILITY; SURFACE PROPERTY; THERANOSTIC NANOMEDICINE; TUMOR CELL LINE;

3T3 CELLS; ANIMALS; CELL LINE; CELL LINE, TUMOR; CHITOSAN; DOXORUBICIN; DRUG CARRIERS; DRUG DELIVERY SYSTEMS; HUMANS; HYDROPHOBIC AND HYDROPHILIC INTERACTIONS; LACTIC ACID; MAGNETICS; MICE; MICROSCOPY, CONFOCAL; MICROSCOPY, ELECTRON, SCANNING; MICROSPHERES; NANOPARTICLES; NANOTECHNOLOGY; POLYGLYCOLIC ACID; POLYMERS; QUANTUM DOTS; RATS; SOLUBILITY; SURFACE PROPERTIES; THERANOSTIC NANOMEDICINE; WATER;

EID: 84924024870     PISSN: 16136810     EISSN: 16136829     Source Type: Journal    
DOI: 10.1002/smll.201402073     Document Type: Article

References (34)

1. M. Alazraki, The 10 biggest-selling drugs that are about to lose their patent, http://www.dailyfinance.com/2011/02/27/top-selling-drugs-are-about-to-lose-patent-protection-ready, accessed: December, 2013.
2. T. Staton, Top 10 drug patent losses of 2014, http://www.fiercepharma.com/special-reports/top-10-drug-patentlosses-2014, accessed: December, 2013.
3. S. C. Mehta, S. S. Mehta, Health Mark. Q. 1997, 14, 107.
4. S. Zhang, Eli Lilly sees buyouts as answer to patent expirations, http://news.medill.northwestern.edu/chicago/news.aspx?id=228087, accessed: March, 2014.
5. P. Wright, Modified release formulations give new life to drugs, http://www.pharmaceuticalcommerce.com/index.php?pg=manufacturing-and-packaging&articleid=27193&keyword=drugs-pharmacology-technologies-FDA, accessed: July, 2014.
6. K. H. Bae, H. J. Chung, T. G. Park, Mol. Cells 2011, 31, 295.
7. X. Jiang, Y. Zheng, H. H. Chen, K. W. Leong, T. H. Wang, H. Q. Mao, Adv. Mater. 2010, 22, 2556.
8. H. G. Bagaria, M. S. Wong, J. Mater. Chem. 2011, 21, 9454.
9. K. Cho, X. Wang, S. Nie, Z. Chen, D. M. Shin, Clin. Cancer Res. 2008, 14, 1310.
10. P. Matteini, M. R. Martina, G. Giambastiani, F. Tatini, R. Cascella, F. Ratto, C. Cecchi, G. Caminati, L. Dei, R. Pini, J. Mater. Chem. B 2013, 1, 1096.
11. J. Xu, Q. Zhao, Y. Jin, L. Qiu, Nanomedicine 2014, 10, 349.
12. B. A. Kairdolf, A. M. Smith, T. H. Stokes, M. D. Wang, A. N. Young, S. Nie, Annu. Rev. Anal. Chem. 2013, 6, 143.
13. P. Zrazhevskiy, L. D. True, X. H. Gao, Nat. Protoc. 2013, 8, 1852.
14. H. Y. Xie, C. Zuo, Y. Liu, Z. L. Zhang, D. W. Pang, X. L. Li, J. P. Gong, C. Dickinson, W. Zhou, Small 2005, 1, 506.
15. L. Dong, D. An, M. Gong, Y. Lu, H. L. Gao, Y. J. Xu, S. H. Yu, Small 2013, 9, 3235.
16. K. M. Gallagher, O. I. Corrigan, J. Contr. Release 2000, 69, 261.
17. R. A. Jain, C. T. Rhodes, A. M. Railkar, A. W. Malick, N. H. Shah, Eur. J. Pharm. Biopharm. 2000, 50, 257.
18. A. Lamprecht, N. Ubrich, M. Hombreiro Pérez, C. M. Lehr, M. Hoffman, P. Maincent, Int. J. Pharm. 2000, 196, 177.
19. C. Sturesson, L. D. Wikingsson, J. Control. Release 2000, 68, 441.
20. D. R. Kalaria, G. Sharma, V. Beniwal, M. N. Ravi Kumar, Pharm Res. 2009, 26, 492.
21. N. Pirooznia, S. Hasannia, A. S. Lotfi, M. Ghanei, J. Nanobiotechnology 2012, 10, 20.
22. D. Lu, M. Huang, C. Xu, W. Yang, C. Hu, L. Lin, L. Tong, M. Li, W. Lu, X. Zhang, J. Ding, BMC Pharmacol. 2005, 5, 11.
23. Y. Matsumura, H. Maeda, Cancer Res. 1986, 46, 6387.
24. K. Greish, J. Drug Target. 2007, 15, 457.
25. R. K. Jain, Adv. Drug Deliv. Rev. 2001, 46, 149.
26. A. Gabizon, J. Liposome Res. 1995, 5, 705.
27. H. Maeda, J. Wu, T. Sawa, Y. Matsumura, K. Hori, J. Control. Release 2000, 65, 271.
28. M. Geiser, B. M. Rothen-Rutishauser, N. Kapp, S. Schurch, W. Kreyling, H. Schulz, M. Semmler, V. Im Hof, J. Heyder, P. Gehr, Environ. Health Perspect 2005, 113, 1555.
29. B. M. Rothen-Rutishauser, S. Schurch, B. Haenni, N. Kapp, P. Gehr, Environ. Sci. Technol. 2006, 40, 4353.
30. R. Luo, B. Neu, S. S. Venkatraman, Small 2012, 8, 2585.
31. B. O. Dabbousi, J. Rodriguez-Viejo, F. V. Mikulec, J. R. Heine, H. Mattoussi, R. Ober, K. F. Jensen, M. G. Bawendi, J. Phys. Chem. B 1997, 101, 9463.
32. S. K. Sahooa, J. Panyama, S. Prabhaa, V. Labhasetwar, J. Control. Release 2002, 82, 105.
33. W. W. Yu, L. H. Qu, W. Z. Guo, X. G. Peng, Chem. Mater. 2003, 15, 2854.
34. K. Y. Win, S. S. Feng, Biomaterials 2005, 26, 2713.